Nicole Randall, MD, Adult Hematologist-Oncologist at IHTC

Get to know Dr. Randall

Dr. Randall is a board-certified Adult Hematologist-Oncologist at the Indiana Hemophilia and Thrombosis Center (IHTC).

Education & Training

Indiana University School of Medicine | M.D.

Indiana University School of Medicine | Residency

University of Minnesota | Hematology-Oncology Fellowship

Certifications & Licensure

Indiana State Medical License

American Board of Medical Specialties, Hematology

American Board of Medical Specialties, Medical Oncology

American Board of Internal Medicine

Societies & Honors

American Society of Clinical Oncology

American Society of Hematology

International Society on Thrombosis and Haemostasis

Expertise & Special Interests

Hemophilia

von Willebrand Disease (VWD)

Thrombosis

Hypercoagulability

Anemias

Hematologic Issues in Pregnancy

Hospital Affiliations

St. Vincent Hospital, Indianapolis

St. Vincent Hospital, Carmel

St. Vincent Hospital, Fishers

St. Vincent Seton Specialty Hospital

St. Vincent Heart Center

Indiana University Health

Indiana University Health North

Indiana University Health Methodist Hospital

Indiana University Health Saxony Hospital

Indiana University Health Morgan Hospital

Publications

The Impact of Agent Orange Exposure on Prognosis and Management in Patients with Chronic Lymphocytic Leukemia: A National Veteran Affairs Tumor Registry Study. Leuk Lymphoma. 2017 Sep;14:1-8. Mescher C., Randall, N,M., Morrison V.M. Baumann-Kreuziger, L., Tarchand G, Tomaska J, and Gilbertson D.

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD. Haematologica. 2016 Aug;101(8):E348-51. Eckfeldt C.E., Randall, N.M., Shanley, R., Yohe S., Bejanyan N., Dolan M., Warlick E., Veneris M., Brunstein C., Wagner J., Weisdorf D.J., and Ustun C.

Inhibiting Tyrosine Kinase Inhibitor, is ineffective in Advanced Systemic Mastocytosis. Am J Hematol. 2015 Apr;90(4):E74. Randall, N.M., Courville E, Afrin, L. and Ustun C. Bosutinib, a LYN/BTK.

More publications by Dr. Randall

A short interview with Dr. Randall

What do you like about IHTC and its approach to care?

One of the reasons that I chose to work at the IHTC is because I support their belief of equal access to excellent medical care for all.

What inspires you about your work?

Being involved in and seeing my patients’ medical conditions improve as the result of IHTC’s excellent care is very inspiring. It’s exhilarating to hear how our patients with hemophilia and other rare bleeding disorders accomplish great feats that they themselves did not believe were possible!

What do you hope to accomplish for patients?

It’s my hope that my patients will leave my office feeling like I was able to explain their complex medical issues in a way that is easy to understand, and that they feel confident with the next steps in evaluation and their treatment plan going forward.